These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2867032)

  • 1. In vivo inhibition of anti-Thy-1 response by monoclonal antibody to the A molecules of the responder.
    Zaleski MB; Gorzynski TJ; Quackenbush LJ; Dowjat WK
    Immunogenetics; 1985; 22(6):673-7. PubMed ID: 2867032
    [No Abstract]   [Full Text] [Related]  

  • 2. Analysis of T-T lymphocytes and T-accessory cell interactions using cloned T cells: MHC I restricted cloned T cells activate MHC II restricted T helper cells.
    Brückner T; Di Pauli R
    Cell Immunol; 1986 Apr; 99(1):182-95. PubMed ID: 2875800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoglobulin-dependent helper T cells: studies in the MOPC-315 system suggest a novel surface antigen phenotype.
    Rohrer JW; Kemp JD
    J Immunol; 1986 Sep; 137(6):1786-92. PubMed ID: 2943802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defects in accessory molecule and other cell surface molecule interactions are responsible for weak mouse helper T-cell responses to xenoantigens.
    Moses RD; Auchincloss H
    Transplant Proc; 1991 Feb; 23(1 Pt 1):883-4. PubMed ID: 1671311
    [No Abstract]   [Full Text] [Related]  

  • 5. The search for H-2 complementation affecting the anti-Thy-1 response in mice: a progress report.
    Reichner JS; Zaleski MB
    Immunol Commun; 1981; 10(6):523-31. PubMed ID: 6119290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Speculations on how Ia antigens (Ir genes) influence the specificity of the immune response.
    McDevitt HO
    Ann Immunol (Paris); 1984; 135D(3):227-36. PubMed ID: 6241451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The proliferating cells in autoimmune MRL/lpr mice lack L3T4, an antigen on "helper" T cells that is involved in the response to class II major histocompatibility antigens.
    Wofsy D; Hardy RR; Seaman WE
    J Immunol; 1984 Jun; 132(6):2686-9. PubMed ID: 6144707
    [No Abstract]   [Full Text] [Related]  

  • 8. MHC-linked immune response suppression mediated by T cells bearing I-A-encoded determinants.
    Araneo BA; Yowell RL
    J Immunol; 1985 Jul; 135(1):73-9. PubMed ID: 2582054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the in vitro presentation of minor lymphocyte stimulating determinants by major histocompatibility complex-encoded immune response genes.
    Ryan JJ; Miner DW; Mond JJ; Finkelman FD; Woody JN
    J Immunol; 1987 Apr; 138(8):2392-401. PubMed ID: 2435797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
    Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
    Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of class II major histocompatibility complex and Thy 1.2 antigens on mouse decidua.
    Searle RF; Matthews CJ
    Placenta; 1988; 9(1):57-64. PubMed ID: 2896348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of helper-T-cell proliferation by recognition of Ia and Mac-1 antigens on phagocytic cells of the thymic reticulum.
    Papiernik M; el Rouby S
    Cell Immunol; 1988 Apr; 113(1):95-106. PubMed ID: 2966683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional analysis of antigen processing and major histocompatibility complex class II-restricted presentation.
    Lich JD; Blum JS
    Methods Mol Biol; 2001; 156():49-56. PubMed ID: 11068749
    [No Abstract]   [Full Text] [Related]  

  • 14. Down-regulation of class II major histocompatibility complex molecules on antigen presenting cells after interaction with helper T cells.
    Vidović D; Falcioni F; Bolin DR; Nagy ZA
    Eur J Immunol; 1995 May; 25(5):1326-31. PubMed ID: 7774635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibody to L3T4 blocks the function of T cells specific for class 2 major histocompatibility complex antigens.
    Swain SL; Dialynas DP; Fitch FW; English M
    J Immunol; 1984 Mar; 132(3):1118-23. PubMed ID: 6198377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo effects of GK1.5 (anti-L3T4a) monoclonal antibody on induction and expression of delayed-type hypersensitivity.
    Miller SD; Jenkins MK
    Cell Immunol; 1985 May; 92(2):414-26. PubMed ID: 2859929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy of established tumor with MHC class II and B7.1 cell-based tumor vaccines.
    Ostrand-Rosenberg S; Pulaski BA; Armstrong TD; Clements VK
    Adv Exp Med Biol; 1998; 451():259-64. PubMed ID: 10026883
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of the H-2u haplotype on immune function in F1 hybrid mice. II. F1 antiparent mixed lymphocyte reactivity.
    Fritz RB; Skeen MJ
    Immunogenetics; 1987; 25(3):161-6. PubMed ID: 2951324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific lymphocyte-target cell conjugate formation between tumor-specific helper T-cell hybridomas and IA-bearing RCS tumors and IE-bearing allogeneic cells. I. Role of Ia and both L3T4 and LFA-1 antigens in recognition/binding.
    Ohnishi K; Bonavida B
    J Immunol; 1986 Dec; 137(11):3681-8. PubMed ID: 2946766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Afferent and efferent pathways in T cell responses to MHC class I+, II-hepatocytes.
    Bumgardner GL; Chen S; Hoffman R; Cahill DC; So SK; Platt J; Bach FH; Ascher NL
    Transplantation; 1989 Jan; 47(1):163-70. PubMed ID: 2521406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.